Raloxifene therapy does not affect uterine blood flow in postmenopausal women: a transvaginal Doppler study

Detalhes bibliográficos
Autor(a) principal: Azevedo, George Dantas de
Data de Publicação: 2004
Outros Autores: Prado, Maria Fernanda Massoni do, Ferriani, Rui Alberto, Reis, Rosana Maria dos, Berezowski, Aderson Tadeu, Ribeiro, Tatiane Flores, Silva, Ester, Maranhão, Técia Maria de Oliveira, Sá, Marcos Felipe Silva de
Tipo de documento: Artigo
Idioma: por
Título da fonte: Repositório Institucional da UFRN
Texto Completo: https://repositorio.ufrn.br/jspui/handle/1/2951
Resumo: AZEVEDO, George Dantas de et al. Raloxifene therapy does not affect uterine blood flow in postmenopausal women: a transvaginal Doppler study. Maturitas, Amsterdam, v.47, n.3, p.195-200, 2004
id UFRN_badb436ce12bc2dbb9e75653ee4c440a
oai_identifier_str oai:https://repositorio.ufrn.br:1/2951
network_acronym_str UFRN
network_name_str Repositório Institucional da UFRN
repository_id_str
spelling Azevedo, George Dantas dePrado, Maria Fernanda Massoni doFerriani, Rui AlbertoReis, Rosana Maria dosBerezowski, Aderson TadeuRibeiro, Tatiane FloresSilva, EsterMaranhão, Técia Maria de OliveiraSá, Marcos Felipe Silva de2010-09-03T16:49:32Z2010-09-03T16:49:32Z2004AZEVEDO, G. D.; PRADO, M. F. M. ; FERRIANI, R. A.; REIS, R. M.; BEREZOWSKI, A. T.; RIBEIRO, T. F.; SILVA, E.; MARAMHÃO, T. M. O.; SA. M. F. S. (2004)https://repositorio.ufrn.br/jspui/handle/1/2951AZEVEDO, George Dantas de et al. Raloxifene therapy does not affect uterine blood flow in postmenopausal women: a transvaginal Doppler study. Maturitas, Amsterdam, v.47, n.3, p.195-200, 2004Objective:To monitor the effects of raloxifene therapy on the uterus of postmenopausalwomen by transvaginal ultrasonography and color flow Doppler. Methods: Twenty-five healthy postmenopausal women were enrolled in this prospective longitudinal study performed at Department of Gynecology and Obstetrics, Faculty of Medicine of Ribeirão Preto. The patients were treated with raloxifene hydrochloride (60 mg per day) for 6 months. All were submitted to transvaginal ultrasound examination with color flow Doppler (ATL-HDI 3000 equipment) before the beginning and after 1, 3 and 6 months of treatment. Resistance index (RI) and pulsatility index (PI) of the uterine arteries were determined by the Doppler method, being considered as indicators of uterine perfusion. The following variables were analyzed: endometrial thickness, uterine volume, RI, and PI. Data were analyzed statistically by repeated-measures analysis of variance. Results: Before treatment, endometrial thickness was 3.38 ± 0.73 mm, and similar values were observed after 1, 3 and 6 months of treatment (3.04 ± 0.82; 3.3 ± 0.83; and 3.37 ± 0.79, respectively) (P > 0.05). No significant differences in uterine volume were observed between the pre- and post-treatment periods. Uterine artery perfusion as indicated by RI and PI measured by Doppler also showed no significant variation, with a high impedance flow being maintained throughout treatment. Conclusions: In the group studied here, raloxifene treatment at the dose of 60 mg per day for 6 months did not induce significant changes in endometrial thickness, uterine volume or uterine artery perfusion, confirming that short-term raloxifene treatment does not affect the uterus of postmenopausal womenporMenopauseClimacterySelective estrogen receptor modulatorRaloxifeneDopplerEndometriumRaloxifene therapy does not affect uterine blood flow in postmenopausal women: a transvaginal Doppler studyinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UFRNinstname:Universidade Federal do Rio Grande do Norte (UFRN)instacron:UFRNORIGINALRaloxifeneTherapyAffect_Azevedo_2004.pdfRaloxifeneTherapyAffect_Azevedo_2004.pdfapplication/pdf70396https://repositorio.ufrn.br/bitstream/1/2951/1/RaloxifeneTherapyAffect_Azevedo_2004.pdfdd1cabbf83e1c043535546f7fe8cf773MD51LICENSElicense.txtlicense.txttext/plain; charset=utf-81748https://repositorio.ufrn.br/bitstream/1/2951/2/license.txt8a4605be74aa9ea9d79846c1fba20a33MD52TEXT2004Art_TeciaMOM_Raloxifene.pdf.txt2004Art_TeciaMOM_Raloxifene.pdf.txtExtracted texttext/plain25115https://repositorio.ufrn.br/bitstream/1/2951/7/2004Art_TeciaMOM_Raloxifene.pdf.txta077c052e54c0c72fcd1534eb4cfbe7bMD57THUMBNAIL2004Art_TeciaMOM_Raloxifene.pdf.jpg2004Art_TeciaMOM_Raloxifene.pdf.jpgIM Thumbnailimage/jpeg3589https://repositorio.ufrn.br/bitstream/1/2951/8/2004Art_TeciaMOM_Raloxifene.pdf.jpgc7ed454d0bfa7b6ef65ed66d82354ae7MD581/29512021-11-12 15:41:18.474oai:https://repositorio.ufrn.br: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Repositório de PublicaçõesPUBhttp://repositorio.ufrn.br/oai/opendoar:2021-11-12T18:41:18Repositório Institucional da UFRN - Universidade Federal do Rio Grande do Norte (UFRN)false
dc.title.pt_BR.fl_str_mv Raloxifene therapy does not affect uterine blood flow in postmenopausal women: a transvaginal Doppler study
title Raloxifene therapy does not affect uterine blood flow in postmenopausal women: a transvaginal Doppler study
spellingShingle Raloxifene therapy does not affect uterine blood flow in postmenopausal women: a transvaginal Doppler study
Azevedo, George Dantas de
Menopause
Climactery
Selective estrogen receptor modulator
Raloxifene
Doppler
Endometrium
title_short Raloxifene therapy does not affect uterine blood flow in postmenopausal women: a transvaginal Doppler study
title_full Raloxifene therapy does not affect uterine blood flow in postmenopausal women: a transvaginal Doppler study
title_fullStr Raloxifene therapy does not affect uterine blood flow in postmenopausal women: a transvaginal Doppler study
title_full_unstemmed Raloxifene therapy does not affect uterine blood flow in postmenopausal women: a transvaginal Doppler study
title_sort Raloxifene therapy does not affect uterine blood flow in postmenopausal women: a transvaginal Doppler study
author Azevedo, George Dantas de
author_facet Azevedo, George Dantas de
Prado, Maria Fernanda Massoni do
Ferriani, Rui Alberto
Reis, Rosana Maria dos
Berezowski, Aderson Tadeu
Ribeiro, Tatiane Flores
Silva, Ester
Maranhão, Técia Maria de Oliveira
Sá, Marcos Felipe Silva de
author_role author
author2 Prado, Maria Fernanda Massoni do
Ferriani, Rui Alberto
Reis, Rosana Maria dos
Berezowski, Aderson Tadeu
Ribeiro, Tatiane Flores
Silva, Ester
Maranhão, Técia Maria de Oliveira
Sá, Marcos Felipe Silva de
author2_role author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Azevedo, George Dantas de
Prado, Maria Fernanda Massoni do
Ferriani, Rui Alberto
Reis, Rosana Maria dos
Berezowski, Aderson Tadeu
Ribeiro, Tatiane Flores
Silva, Ester
Maranhão, Técia Maria de Oliveira
Sá, Marcos Felipe Silva de
dc.subject.por.fl_str_mv Menopause
Climactery
Selective estrogen receptor modulator
Raloxifene
Doppler
Endometrium
topic Menopause
Climactery
Selective estrogen receptor modulator
Raloxifene
Doppler
Endometrium
description AZEVEDO, George Dantas de et al. Raloxifene therapy does not affect uterine blood flow in postmenopausal women: a transvaginal Doppler study. Maturitas, Amsterdam, v.47, n.3, p.195-200, 2004
publishDate 2004
dc.date.issued.fl_str_mv 2004
dc.date.accessioned.fl_str_mv 2010-09-03T16:49:32Z
dc.date.available.fl_str_mv 2010-09-03T16:49:32Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.citation.fl_str_mv AZEVEDO, G. D.; PRADO, M. F. M. ; FERRIANI, R. A.; REIS, R. M.; BEREZOWSKI, A. T.; RIBEIRO, T. F.; SILVA, E.; MARAMHÃO, T. M. O.; SA. M. F. S. (2004)
dc.identifier.uri.fl_str_mv https://repositorio.ufrn.br/jspui/handle/1/2951
identifier_str_mv AZEVEDO, G. D.; PRADO, M. F. M. ; FERRIANI, R. A.; REIS, R. M.; BEREZOWSKI, A. T.; RIBEIRO, T. F.; SILVA, E.; MARAMHÃO, T. M. O.; SA. M. F. S. (2004)
url https://repositorio.ufrn.br/jspui/handle/1/2951
dc.language.iso.fl_str_mv por
language por
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.source.none.fl_str_mv reponame:Repositório Institucional da UFRN
instname:Universidade Federal do Rio Grande do Norte (UFRN)
instacron:UFRN
instname_str Universidade Federal do Rio Grande do Norte (UFRN)
instacron_str UFRN
institution UFRN
reponame_str Repositório Institucional da UFRN
collection Repositório Institucional da UFRN
bitstream.url.fl_str_mv https://repositorio.ufrn.br/bitstream/1/2951/1/RaloxifeneTherapyAffect_Azevedo_2004.pdf
https://repositorio.ufrn.br/bitstream/1/2951/2/license.txt
https://repositorio.ufrn.br/bitstream/1/2951/7/2004Art_TeciaMOM_Raloxifene.pdf.txt
https://repositorio.ufrn.br/bitstream/1/2951/8/2004Art_TeciaMOM_Raloxifene.pdf.jpg
bitstream.checksum.fl_str_mv dd1cabbf83e1c043535546f7fe8cf773
8a4605be74aa9ea9d79846c1fba20a33
a077c052e54c0c72fcd1534eb4cfbe7b
c7ed454d0bfa7b6ef65ed66d82354ae7
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
repository.name.fl_str_mv Repositório Institucional da UFRN - Universidade Federal do Rio Grande do Norte (UFRN)
repository.mail.fl_str_mv
_version_ 1814832675662331904